iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML

Stopped Study design modified to collect specimens from a bank requiring a separate IRB-approved protocol.

Conditions

• Acute Leukemia
• Myelodysplastic Syndromes
• AML
• MDS

Interventions

• DIAGNOSTIC_TEST: droplet digital PCR

Sponsor

University of Florida